Heart failure nursing: assessment, interventions, and management

Heart failure affects approximately 6.7 million adults in the United States and is the leading cause of hospitalization in patients over 65. Despite advances in pharmacotherapy, the 30-day readmission rate remains around 20% — a metric directly influenced by nursing care quality. For nursing students, heart failure is among the highest-yield NCLEX topics and one of the most frequently encountered diagnoses across all clinical settings. This reference covers classification, pathophysiology, assessment, nursing interventions, pharmacology (including newer agents), acute decompensation management, and patient education.

Cross-reference this page with the atrial fibrillation nursing reference — AFib is both a cause and consequence of heart failure — and the hypertension nursing reference, since hypertension is the leading cause of HFpEF and a major driver of cardiac remodeling.

Classification: HFrEF vs HFpEF

Heart failure is classified primarily by ejection fraction (EF) — the percentage of blood ejected from the left ventricle with each contraction, measured on echocardiography.

Clinical insight: HFpEF now accounts for over 50% of all heart failure diagnoses. It is harder to treat than HFrEF — there are far fewer evidence-based mortality-reducing therapies — and its prevalence continues to grow with an aging, more obese population.

NYHA functional classification

The New York Heart Association (NYHA) classification describes symptom burden and guides medication selection. Several drugs (notably spironolactone and digoxin) are indicated specifically for Class II–IV disease. NCLEX questions frequently test NYHA class definitions.

AHA/ACC staging

The AHA/ACC staging system (2022 guidelines, A–D) complements NYHA by tracking disease progression. Unlike NYHA class, AHA/ACC stage can only advance — it does not improve with treatment.

Pathophysiology

Heart failure is a clinical syndrome in which the heart cannot pump sufficient blood to meet the body’s metabolic needs, or can do so only at the cost of abnormally elevated filling pressures. Understanding why compensatory mechanisms eventually fail explains both symptoms and pharmacotherapy.

Compensatory mechanisms

When cardiac output falls, three overlapping responses are activated:

Frank-Starling mechanism: Increased preload (venous return) stretches the ventricle, and up to a point, this increases contractile force. Beyond the optimal stretch, however, the ventricle becomes overfilled and contractility actually falls — the ascending Starling curve becomes a descending one. This is why volume overload worsens rather than corrects cardiac output in heart failure.

Sympathetic nervous system (SNS) activation: Reduced cardiac output triggers baroreceptor-mediated catecholamine release (epinephrine, norepinephrine). This increases heart rate, contractility, and causes peripheral vasoconstriction. Short-term these effects maintain perfusion pressure; long-term, SNS overdrive increases myocardial oxygen demand, causes direct myocardial toxicity, and promotes maladaptive remodeling — which is why beta-blockers improve survival in HFrEF despite initially seeming counterintuitive.

RAAS activation: Reduced renal perfusion pressure triggers renin release from the juxtaglomerular cells. Renin converts angiotensinogen to angiotensin I → angiotensin II (via ACE). Angiotensin II causes potent vasoconstriction and stimulates aldosterone secretion from the adrenal cortex. Aldosterone promotes sodium and water retention in the renal collecting duct, expanding blood volume. Chronically, this causes progressive volume overload, worsens congestion, and drives cardiac fibrosis — explaining why ACE inhibitors, ARBs, and aldosterone antagonists form the pharmacologic backbone of HFrEF treatment.

Forward vs backward failure

These concepts explain which direction symptoms originate from:

• Forward failure: Insufficient cardiac output delivered to the periphery → fatigue, weakness, poor exercise tolerance, cool extremities, decreased urine output, altered cognition
• Backward failure: Blood backs up behind the failing ventricle → elevated filling pressures and venous congestion. Left-sided backward failure → pulmonary venous congestion. Right-sided backward failure → systemic venous congestion.

Most patients experience both simultaneously. When left heart failure is sustained, elevated pulmonary arterial pressures eventually strain the right ventricle, producing biventricular failure with combined findings.

Decompensation triggers

Patients with compensated chronic heart failure decompensate when a physiologic stress overwhelms remaining cardiac reserve. Common triggers nurses should recognize:

• Dietary sodium excess or fluid intake exceeding restriction
• Medication non-adherence (particularly diuretics and neurohormonal agents)
• New-onset or rapid-ventricular-response atrial fibrillation (see AFib nursing reference)
• Sepsis — myocardial depression plus systemic vasodilation (see sepsis nursing reference)
• Cardiac ischemia or new MI
• Pulmonary embolism
• Worsening renal function (cardiorenal syndrome)
• Hypertensive crisis (see hypertension nursing reference)
• Thyroid dysfunction (hyperthyroidism increases cardiac demand)
• Anemia — decreased oxygen delivery demands increased cardiac output

Clinical assessment

Left vs right heart failure findings

The side of the heart that fails determines the direction of congestion.

Key physical exam findings

S3 gallop: Often called the “Ken-tuc-ky” gallop (S1–S2–S3). Heard best at the apex with the bell of the stethoscope in the left lateral decubitus position. Represents rapid ventricular filling against an already elevated filling pressure. In adults, an S3 is pathological and one of the most specific signs of systolic HF or elevated left atrial pressure.

JVD assessment: Position the patient at 45°. Use tangential lighting. The external jugular vein (or the pulsating column in the internal jugular) should not be visible above the clavicle at 45° in a healthy patient. Identify the top of the venous column and measure vertically to the sternal angle; add 5 cm (the fixed sternal angle-to-right atrium distance). A total CVP estimate > 8–10 cm H₂O indicates elevated right-sided filling pressure.

Pulmonary assessment: Crackles in heart failure are typically fine, bibasilar, and inspiratory. They do not clear with coughing (unlike secretion-related coarse crackles). In severe pulmonary edema, crackles extend to mid-lung or the entire lung field. Wheezing (“cardiac asthma”) can occur from airway edema.

Hemodynamic parameters to monitor:

• Blood pressure — hypotension suggests forward failure and cardiogenic shock risk; hypertension may indicate a hypertensive trigger
• Heart rate — tachycardia is compensatory; look for new AFib (see EKG interpretation cheat sheet)
• Respiratory rate — tachypnea with SpO2 decline indicates worsening pulmonary edema
• Urine output — target ≥ 0.5 mL/kg/hr; oliguria in decompensation may indicate cardiorenal syndrome
• Daily weight — the most sensitive early indicator of fluid retention

Diagnostic findings

BNP and NT-proBNP

B-type natriuretic peptide (BNP) is released from ventricular myocytes in response to wall stretch from volume overload and elevated filling pressures. It is the most important biomarker for diagnosing and monitoring heart failure. Reference ranges are in the nursing lab values cheat sheet.

• BNP < 100 pg/mL: Heart failure unlikely
• BNP 100–400 pg/mL: Intermediate — clinical context required
• BNP > 400 pg/mL: Heart failure likely; > 1,000 pg/mL associated with high mortality
• NT-proBNP < 300 pg/mL: Heart failure unlikely (all ages)
• NT-proBNP thresholds for HF likely: Age < 50 → > 450 pg/mL; age 50–75 → > 900 pg/mL; age > 75 → > 1,800 pg/mL

Critical caveat: Patients on sacubitril/valsartan (Entresto) have elevated BNP levels because neprilysin — the enzyme that degrades natriuretic peptides — is inhibited. In these patients, use NT-proBNP, not BNP, for monitoring.

BNP is also elevated in renal failure (decreased clearance) and falsely low in obesity (adipose tissue clears BNP). Always interpret in clinical context.

Echocardiography

Transthoracic echocardiography (TTE) is the essential diagnostic study. It measures EF (defining HFrEF vs HFpEF), identifies wall motion abnormalities from prior ischemia, evaluates valve function, estimates pulmonary artery pressures, and detects pericardial effusion. Every new heart failure diagnosis requires an echo. EF measurement is the basis for all pharmacotherapy and device therapy decisions.

Chest X-ray

CXR findings correlate with severity of congestion:

• Cardiomegaly: Cardiothoracic ratio > 0.5 on PA projection
• Pulmonary vascular redistribution (cephalization): Upper lobe pulmonary vessels more prominent than lower lobe — early sign of elevated left atrial pressure
• Kerley B lines: Short horizontal lines perpendicular to the pleural surface at the lung bases — represent fluid in interlobular septa
• Interstitial edema: Hazy, indistinct vascular markings; “ground glass” appearance
• Bat-wing (butterfly) infiltrates: Bilateral perihilar haziness — classic pattern of acute alveolar pulmonary edema
• Pleural effusions: Blunting of costophrenic angles; usually bilateral, right-predominant

Laboratory panel

Nursing interventions

The following priority-ordered interventions address the core physiologic derangements in heart failure: volume overload, impaired oxygenation, electrolyte shifts, and deconditioning risk.

Pharmacology

Critical NCLEX distinction: Metoprolol succinate (extended-release) has proven HFrEF mortality benefit. Metoprolol tartrate (immediate-release) does NOT share this indication and is not interchangeable. Always clarify the formulation in orders.

ARNi washout rule: Never start sacubitril/valsartan without confirming the patient has been off all ACE inhibitors for at least 36 hours. Combining them with ACEi — even with an overlap of hours — dramatically increases angioedema risk.

Acute decompensated heart failure (ADHF)

Acute decompensated heart failure occurs when the compensated state fails and the patient develops rapid hemodynamic deterioration, pulmonary edema, or end-organ hypoperfusion. Recognizing ADHF early and initiating the correct interventions within the first hour is critical.

Recognition

Key ADHF presentations:

• Worsening dyspnea, orthopnea, PND over days (gradual decompensation — most common)
• Acute flash pulmonary edema (sudden onset severe dyspnea with pink frothy sputum)
• Fatigue and decreased urine output without significant edema (low-output syndrome)
• Weight gain of > 5 lbs over 1 week

Forrester-Diamond hemodynamic subsets

One of the most powerful frameworks for understanding ADHF — and rarely taught in standard nursing resources — is the Forrester-Diamond classification. It categorizes patients by two axes: perfusion adequacy (warm vs cold) and congestion status (wet vs dry).

Why this matters clinically: A “cold and wet” patient who is aggressively diuresed without addressing the low-output state will develop worsening renal failure, hypotension, and clinical deterioration. The hemodynamic subset guides whether the priority is diuresis, vasodilation, or inotropic support.

LMNOP protocol — with an important update

The LMNOP mnemonic is still taught in nursing programs for managing acute pulmonary edema:

• L — Loop diuretic (furosemide IV): Reduces preload through diuresis; early IV administration is a priority
• M — Morphine: Historically used to reduce preload and anxiety. Morphine is no longer routinely recommended for ADHF. Retrospective studies (including ADHERE registry data) found morphine associated with increased rates of mechanical ventilation, ICU admission, and mortality. Some guidelines now list morphine as potentially harmful in ADHF. It may still be used in palliative/comfort contexts, but is not a first-line ADHF intervention.
• N — Nitrates (nitroglycerin IV): Potent venodilator at low doses; arterial dilator at higher doses — reduces preload and afterload; rapid onset; effective for hypertensive acute pulmonary edema
• O — Oxygen: Supplemental O2 targeting SpO2 ≥ 94%; CPAP/BiPAP for moderate-severe cases
• P — Position (upright): High Fowler or dangling legs; maximizes respiratory excursion and reduces venous return

Nursing priorities in ADHF:

1. Upright position, supplemental O2 / NIV
2. Large-bore IV access (two peripheral IVs if possible)
3. Continuous cardiac monitoring + 12-lead EKG
4. Stat BNP, BMP, troponin, ABG (see ABG interpretation reference)
5. Administer IV furosemide and vasodilators as ordered
6. Strict hourly I&O; assess urine output response within 60 minutes of diuretic
7. Prepare for intubation if no response to NIV

Patient education

Discharge education is among the most impactful nursing interventions for reducing heart failure readmissions. The most effective teaching approach is teach-back — ask the patient to explain instructions in their own words.

Daily weight monitoring:

• Weigh every morning after waking and voiding, before eating, in similar clothing
• Record the weight in a logbook or home monitoring app
• Call your provider if you gain 2 lbs in one day or 5 lbs in one week
• Do not wait for shortness of breath — weight gain is an earlier warning sign

When to call the provider or go to the emergency department:

• Weight gain of 2 lbs in 24 hours or 5 lbs in 1 week
• Increased shortness of breath, especially lying flat or at rest
• Waking up at night unable to breathe
• Legs becoming more swollen
• Feeling dizzy or faint
• New irregular heartbeat
• Reduced urine output

Low-sodium diet (2 g/day):

• Most processed foods, canned soups, and restaurant meals far exceed safe sodium limits
• Read all food labels: target < 600 mg sodium per serving; avoid anything > 800 mg/serving
• Use herbs and spices for flavor instead of salt; avoid salt substitutes containing potassium chloride if on ACEi/ARB/MRA (hyperkalemia risk)
• Avoid fast food, deli meats, pickled foods, and salty snacks

Fluid restriction (1.5–2 L/day when prescribed):

• Includes all liquids: water, juice, milk, coffee, tea, soup, ice chips, gelatin, ice cream
• Use small cups; spread fluid intake across the day
• Sucking on ice chips or hard candy can relieve thirst without significant fluid intake

Medication adherence:

• Do not skip doses, especially diuretics and heart failure medications
• Never stop beta-blockers abruptly without provider guidance — rebound tachycardia and hypertension
• Know the names and purposes of each medication
• Bring a medication list to all appointments and hospitalizations

Activity guidelines:

• Gradually increase activity as tolerated; report dyspnea, chest pain, or palpitations with activity
• Avoid activities during the hottest part of the day; heat causes vasodilation and can worsen hypotension
• Cardiac rehabilitation is available and improves long-term outcomes — ask your provider for a referral
• Plan rest periods between activities; stop before feeling exhausted

NCLEX-style practice questions

Question 1

A nurse is caring for a patient admitted with acute decompensated heart failure. Assessment findings include dyspnea, orthopnea, bibasilar crackles, and an S3 gallop. Which is the nurse’s priority intervention?

A) Administer oral furosemide as scheduled B) Elevate the head of bed to 30–45° and apply supplemental oxygen C) Insert a urinary catheter for strict I&O D) Obtain a stat 12-lead EKG

Answer: B — position and oxygenation are the immediate priorities

Rationale: In acute decompensated left heart failure with dyspnea and crackles, positioning the patient upright reduces preload (venous return), improves lung compliance, and decreases work of breathing. Supplemental oxygen corrects hypoxemia. These interventions can be initiated immediately without a physician order. Oral furosemide (A) is appropriate but IV is preferred in acute decompensation for faster diuresis. Urinary catheter (C) and EKG (D) are important but not the first priority over addressing airway/breathing/circulation — the ABCs.

Question 2

A physician orders metoprolol tartrate 25 mg PO BID for a patient with a new diagnosis of HFrEF (EF 30%). The nurse should take which action?

A) Administer the medication as ordered B) Hold the medication — beta-blockers are contraindicated in all heart failure C) Clarify the order — metoprolol succinate (extended-release) is the approved HFrEF formulation, not tartrate D) Administer metoprolol tartrate and monitor closely for bradycardia

Answer: C — clarify the formulation

Rationale: Only three beta-blockers have proven mortality benefit in HFrEF: carvedilol, metoprolol succinate (extended-release, Toprol XL), and bisoprolol. Metoprolol tartrate (immediate-release) is NOT approved for HFrEF and does not carry the same evidence. This is a medication safety issue — clarifying the order is the correct action. Beta-blockers are not contraindicated in stable HFrEF (B is wrong) but must not be initiated during acute decompensation.

Question 3

A patient with HFrEF was on lisinopril for 2 years. The provider discontinues lisinopril today and plans to start sacubitril/valsartan (Entresto) to improve outcomes. The nurse should plan to administer the first Entresto dose at what time?

A) Tonight — start as soon as the lisinopril is discontinued B) Tomorrow morning — 12 hours is an adequate washout period C) In 36 hours — a mandatory washout period from ACE inhibitors is required D) In 7 days — Entresto cannot be started within 1 week of ACEi discontinuation

Answer: C — 36-hour mandatory washout

Rationale: Combining sacubitril/valsartan with an ACE inhibitor significantly increases bradykinin levels (both agents impair bradykinin degradation via different mechanisms), dramatically increasing the risk of potentially life-threatening angioedema. A mandatory minimum 36-hour washout period from any ACE inhibitor is required before initiating sacubitril/valsartan. The 36-hour window is a specific, testable fact frequently seen on NCLEX pharmacology questions.

Question 4

A nurse reviews morning labs for a patient with heart failure on furosemide 80 mg PO daily and digoxin 0.125 mg PO daily. Results: K+ 3.0 mEq/L, digoxin level 0.8 ng/mL. What is the nurse’s priority action?

A) Administer both medications — the digoxin level is within the therapeutic range B) Hold the digoxin, notify the provider, and anticipate a potassium replacement order C) Administer the furosemide and reassess potassium in 4 hours D) Hold both medications and wait for a provider to reassess the patient

Answer: B — hold digoxin, notify provider, anticipate potassium replacement

Rationale: Even at a therapeutic digoxin level (0.8 ng/mL is within the 0.5–0.9 range), hypokalemia dramatically potentiates digoxin toxicity. Potassium competes with digoxin for the Na-K-ATPase binding site — when potassium is low, digoxin binds more avidly and toxic effects occur at lower serum levels. A K+ of 3.0 mEq/L (normal 3.5–5.0) is significantly low and must be corrected before administering digoxin. The nurse should hold digoxin, notify the provider, and anticipate K+ replacement. Administering furosemide (C) would worsen hypokalemia. See the electrolyte imbalances nursing reference for potassium replacement guidance.

Question 5

A patient with heart failure is classified as Forrester-Diamond “cold and wet.” Which hemodynamic picture is consistent with this classification?

A) Adequate perfusion, significant congestion — warm extremities, crackles, edema B) Impaired perfusion, significant congestion — cool extremities, hypotension, crackles, oliguria C) Impaired perfusion, minimal congestion — cool extremities, hypotension, no significant edema D) Adequate perfusion, no congestion — stable outpatient

Answer: B — cold and wet = impaired perfusion + congestion

Rationale: The Forrester-Diamond classification categorizes ADHF patients by perfusion adequacy (warm vs cold) and congestion (wet vs dry). “Cold and wet” describes impaired forward perfusion (cool extremities, hypotension, oliguria, altered mentation) combined with significant congestion (crackles, elevated JVD, edema). This is the highest-risk ADHF profile and typically requires inotropic support and ICU-level care — aggressive diuresis alone would worsen hypoperfusion. Option A describes “warm and wet” (the most common ADHF presentation). Option C is “cold and dry.” Option D is “warm and dry” (compensated HF).

Question 6

A nurse is teaching a patient with heart failure about home monitoring. Which statement by the patient requires the nurse to provide additional teaching?

A) “I will weigh myself every morning before I eat or drink anything.” B) “I will call my doctor if I gain 2 pounds in one day or 5 pounds in one week.” C) “I can wait to call my doctor until I feel short of breath — that’s when HF is getting worse.” D) “I need to limit my sodium intake to 2 grams per day.”

Answer: C — weight gain precedes dyspnea; do not wait for symptoms

Rationale: The critical teaching point is that weight gain from fluid retention occurs before shortness of breath develops. Daily weights are a leading indicator of decompensation — acting on weight gain early can prevent hospitalization. Patients should call their provider at the weight thresholds (2 lbs/day or 5 lbs/week), not wait for dyspnea. All other statements are correct: morning weights before eating (A), both weight thresholds (B), and 2 g sodium restriction (D).

Related references

• Atrial fibrillation nursing reference — AFib is both a trigger for decompensation and a common complication of heart failure; rate control and anticoagulation
• Hypertension nursing reference — leading cause of HFpEF; hypertensive urgency and emergency can precipitate acute decompensation
• EKG interpretation cheat sheet — rhythm monitoring in heart failure: AFib, ventricular arrhythmias, QTc prolongation with electrolyte disturbances
• Nursing lab values cheat sheet — BNP and NT-proBNP thresholds, electrolyte reference ranges, digoxin therapeutic level
• Electrolyte imbalances nursing reference — loop diuretics cause hypokalemia and hypomagnesemia; aldosterone antagonists cause hyperkalemia; hypokalemia potentiates digoxin toxicity
• ABG interpretation reference — respiratory and metabolic compensation in acute pulmonary edema and low-output states
• Sepsis nursing reference — sepsis is a major precipitant of acute decompensation; myocardial depression in sepsis

This article is for educational purposes only. Always apply clinical judgment and follow your institution’s evidence-based protocols when caring for patients with heart failure.